DarioHealth Corp (DRIO)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $14.22M
Last updated: Nov 17, 2026 at 10:57 AM ET
DarioHealth Corp (DRIO) Stock Forecast
Analysts expect DarioHealth (DRIO) to earn -$2.47 per share in the fiscal year ending Dec 31, 2026, on revenue of $21.75M. Of 6 analysts, 5 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.17, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 83% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 5 | 83.3% |
| Hold | 1 | 16.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 35.6%.
- Fiscal year ending Dec 31, 2026
- -$2.47
- EPS consensus, revenue $21.75M
- Fiscal year ending Dec 31, 2027
- -$1.12
- EPS consensus, revenue $29.49M
- Next report
- Mar 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.47 | -$2.48 to -$2.45 | 2 | $21.75M | $21.20M to $22.40M | 5 |
| Dec 31, 2027 | -$1.12 | -$1.46 to -$0.78 | 2 | $29.49M | $25.09M to $40.00M | 6 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.62 | N/A | 5 | $5.55M | $5.19M to $5.92M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.57.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.47 | -$2.81 | -$2.81 | -$2.81 | -$2.57 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.12 | -$0.68 | -$0.68 | -$0.68 | -$0.66 | N/A |
Frequently Asked Questions About DRIO
What is the DRIO stock forecast?
Consensus analyst estimates put DarioHealth's EPS at -$2.47 for the fiscal year ending Dec 31, 2026, on revenue of $21.75M. The consensus rating from 6 analysts is Buy.
How do analysts rate DRIO stock?
Of 6 analysts covering DarioHealth, 0 rate it Strong Buy, 5 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from DRIO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.47, with estimates from -$2.48 to -$2.45 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.12, with estimates from -$1.46 to -$0.78 from 2 analysts.
What revenue do analysts expect from DarioHealth next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $21.75M, with estimates from $21.20M to $22.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $29.49M, with estimates from $25.09M to $40.00M.
How many analysts cover DRIO?
6 analysts rate DarioHealth stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
DRIO pages: Overview, Earnings, Forecast, Financials, Valuation